Seres Therapeutics, Inc. (MCRB)
5.28
-0.28
(-5.04%)
USD |
NASDAQ |
Sep 09, 16:00
5.28
0.00 (0.00%)
After-Hours: 18:10
Seres Therapeutics Total Liabilities (Quarterly) : 67.05M for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 67.05M |
| March 31, 2026 | 91.12M |
| December 31, 2025 | 93.98M |
| September 30, 2025 | 99.78M |
| June 30, 2025 | 110.85M |
| March 31, 2025 | 113.72M |
| December 31, 2024 | 126.03M |
| September 30, 2024 | 154.82M |
| June 30, 2024 | 408.80M |
| March 31, 2024 | 401.00M |
| December 31, 2023 | 403.46M |
| September 30, 2023 | 382.82M |
| June 30, 2023 | 383.77M |
| March 31, 2023 | 318.06M |
| December 31, 2022 | 338.00M |
| September 30, 2022 | 244.28M |
| June 30, 2022 | 250.14M |
| March 31, 2022 | 238.93M |
| December 31, 2021 | 223.35M |
| September 30, 2021 | 220.56M |
| June 30, 2021 | 168.58M |
| March 31, 2021 | 161.99M |
| December 31, 2020 | 168.19M |
| Date | Value |
|---|---|
| September 30, 2020 | 168.15M |
| June 30, 2020 | 166.25M |
| March 31, 2020 | 172.27M |
| December 31, 2019 | 180.76M |
| September 30, 2019 | 156.37M |
| June 30, 2019 | 164.06M |
| March 31, 2019 | 176.88M |
| December 31, 2018 | 168.52M |
| September 30, 2018 | 139.61M |
| June 30, 2018 | 146.21M |
| March 31, 2018 | 149.40M |
| December 31, 2017 | 128.82M |
| September 30, 2017 | 126.37M |
| June 30, 2017 | 128.41M |
| March 31, 2017 | 133.40M |
| December 31, 2016 | 140.02M |
| September 30, 2016 | 143.52M |
| June 30, 2016 | 138.82M |
| March 31, 2016 | 134.64M |
| December 31, 2015 | 11.51M |
| September 30, 2015 | 4.846M |
| June 30, 2015 | 6.368M |
| March 31, 2015 | 5.82M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Agenus, Inc. | 378.54M |
| Amgen, Inc. | 83.95B |
| Anika Therapeutics, Inc. | 46.19M |
| BioCryst Pharmaceuticals, Inc. | 1.012B |
| Imunon, Inc. | 10.80M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 101.59M |
| Shareholders Equity (Quarterly) | 34.53M |
| Debt to Equity Ratio | 1.640 |
| Current Ratio | 2.114 |
| Net Debt Paydown Yield | 8.49% |